Cargando…
Early prediction model for prognosis of patients with hepatitis-B-virus-related acute-on-chronic liver failure received glucocorticoid therapy
BACKGROUND: Early prediction for short-term prognosis is essential for the management of hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF). In this study, we aim to establish a noninvasive model for predicting the 90-day mortality in patients with HBV–ACLF received glucocorticoid...
Autores principales: | Gao, Shuai, Han, Li-Yan, Fan, Yu-Chen, Wang, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661801/ https://www.ncbi.nlm.nih.gov/pubmed/36376930 http://dx.doi.org/10.1186/s40001-022-00891-w |
Ejemplares similares
-
Glucocorticoid Regulates NLRP3 in Acute-On-Chronic Hepatitis B Liver Failure
por: Zhao, Qian, et al.
Publicado: (2019) -
SOCS1 methylation level is associated with prognosis in patients with acute-on-chronic hepatitis B liver failure
por: Li, Feng, et al.
Publicado: (2023) -
Promoter methylation status and expression of PPAR-γ gene are associated with prognosis of acute-on-chronic hepatitis B liver failure
por: Zhao, Ze-Hua, et al.
Publicado: (2015) -
Glucocorticoid versus traditional therapy for hepatitis B virus-related acute-on-chronic liver failure: A systematic review and meta-analysis
por: Gao, Ranran, et al.
Publicado: (2020) -
Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure
por: Li, Tai-Ping, et al.
Publicado: (2019)